Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivmecillinam as Oral Step-Down Treatment for E. Coli Febrile UTI
NCT07236944Phase 4Recruiting
- Sponsor
- Uppsala University
- Start
- Dec 2025
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of pivmecillinam in urinary tract infection (UTI), sponsored by Uppsala University. Started Dec 2025; status: recruiting.
02
Drugs
pivmecillinam
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07236944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236944.